Quantum Biopharma (QNTM) Long-Term Investments (2018 - 2025)

Quantum Biopharma has disclosed Long-Term Investments across 8 years of filings, most recently posting $2224.0 for Q1 2025.

• Long-Term Investments for Q1 2025 came in at $2224.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2025 was $2224.0 (changed N/A YoY), and the FY2024 annual result was $2224.0, down 63.23% from the prior year.
• Long-Term Investments came in at $2224.0 for Q1 2025 at Quantum Biopharma, roughly flat from $2224.0 in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $827612.0 in Q4 2022 to a low of $2224.0 in Q4 2024.
• The 5-year median for Long-Term Investments is $8549.5 (2023), against an average of $157171.0.
• Across the five-year window, Long-Term Investments plunged 99.27% in 2023 and surged 35.2% in 2024, its largest moves.
• Quantum Biopharma's Long-Term Investments stood at $660226.0 in 2021, then grew by 25.35% to $827612.0 in 2022, then slumped by 99.27% to $6049.0 in 2023, then plunged by 63.23% to $2224.0 in 2024, then changed by 0.0% to $2224.0 in 2025.
• The last three Long-Term Investments figures came in at $2224.0 (Q1 2025), $2224.0 (Q4 2024), and $5926.0 (Q3 2024), per Business Quant data.